Related Experiment Videos
Hypocholesterolemic effects of Chinese tea
1Department of Pharmacology, Faculty of Medicine, University of Hong Kong, Hong Kong.
Pharmacological Research
|June 1, 1997
Summary
Unfermented Chinese green and jasmine teas significantly lower high cholesterol in rats. These teas, rich in catechins, also reduced liver weight and improved heart health markers.
Area of Science:
- Nutritional Science
- Pharmacology
- Biochemistry
Background:
- Diet-induced hypercholesterolemia is a significant health concern.
- Tea consumption is associated with various health benefits, including cardiovascular protection.
- Different tea types vary in fermentation levels and bioactive compounds.
Purpose of the Study:
- To investigate the hypocholesterolemic effects of Chinese teas with varying fermentation degrees.
- To identify specific tea components responsible for cholesterol reduction.
- To evaluate the impact of tea extracts on lipid metabolism and atherogenic markers in rats.
Main Methods:
- Rats were fed a cholesterol-enriched diet to induce hypercholesterolemia.
- Different Chinese tea extracts (Green, Jasmine, Iron Buddha, Oolong, Pu erh) were administered for 8 weeks.
- Serum and liver cholesterol levels, liver weight, lipid deposition, atherogenic index, and HDL-total cholesterol ratio were analyzed.
Main Results:
- Chinese Green tea and Jasmine tea demonstrated significant reductions in serum and liver cholesterol.
- These teas also mitigated the increase in liver weight caused by lipid deposition.
- All tea treatments improved the atherogenic index and increased the HDL-total cholesterol ratio.
- Higher catechin levels, particularly (-)-epicatechin gallate and (-)-epigallocatechin gallate, correlated with hypocholesterolemic effects.
Conclusions:
- Minimally fermented Chinese teas, like Green and Jasmine, are effective in managing diet-induced hypercholesterolemia in rats.
- Catechins in these teas are likely responsible for their cholesterol-lowering properties.
- Tea consumption may offer a natural approach to improving cardiovascular health by modulating lipid profiles.